Articles by : Bella Czajkowski, National Correspondent

CMS Nominee ‘Dr. Oz’ Grilled Over Potential Medicaid Cuts and Position on Medicare Negotiations at Confirmation Hearing

March 18, 2025 Bella Czajkowski, National Correspondent Views

The Senate Finance Committee pressed Mehmet Oz, known as "Dr. Oz," on whether he would oppose cuts to Medicaid as CMS administrator. Oliver Oz, his son who is marketed as having a leadership role at a 340B services company, sat behind him during the hearing.

Mehmet Oz, President Donald Trump’s (R) nominee to lead the Centers for Medicare & Medicaid Services (CMS), faced persistent questioning—primarily [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sumitomo, J&J Announce 340B Refunds to Covered Entities

March 18, 2025 Bella Czajkowski, National Correspondent Views

Sumitomo Pharma and Johnson & Johnson announced lists of drugs eligible for refunds.

Two drugmakers recently notified covered entities of adjustments to their 340B drug ceiling prices and resulting refund eligibility. Sumitomo Pharma [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Federal Judge Dismisses Antitrust Class Action Lawsuit Against CVS Over 340B TPA Policy

March 13, 2025 Bella Czajkowski, National Correspondent Views

A federal judge granted CVS' motion to dismiss a case accusing the healthcare company of violating antitrust laws through its use of 340B TPA Wellpartner.

A federal judge ruled that healthcare conglomerate CVS Health did not violate antitrust laws with its contract pharmacy policies, dismissing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Recap of Recent Webinar: A Closer Look at Battles Over State 340B Contract Pharmacy Access Bills and Laws

March 11, 2025 Bella Czajkowski, National Correspondent Views

340B Report's latest webinar overviewed contract pharmacy developments in state legislatures and the courts, plus how a dark money group has ramped up anti-340B ads.

As state legislatures ramp up efforts to protect contract pharmacy access, drug industry lawsuits against existing state laws continue to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Hospital Advocates File Amicus Briefs in Federal Court Cases on Drugmaker 340B Rebate Models, Maryland’s Contract Pharmacy Law

March 11, 2025 Bella Czajkowski, National Correspondent Views

Provider advocates filed multiple briefs in the U.S. District Court for the District of Columbia supporting the federal government's stance that drugmakers cannot implement a 340B rebate model without agency approval.

A coalition of national and local hospital advocacy groups recently filed briefs in multiple federal lawsuits: One that supports the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Florida Providers Concerned New State Medicaid Reimbursement Bill Could Significantly Restrict 340B Savings

March 4, 2025 William Newton and Bella Czajkowski, Associate Editor/Senior Writer Views

Some Florida providers are concerned about the 340B implications of a recently introduced state Medicaid reimbursement bill with ambiguous language.

Florida providers are concerned that a new state bill, which aims to lower Medicaid prices in the state, could significantly [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

House Passes Budget Resolution Despite Concerns Over Medicaid Cuts

February 27, 2025 Bella Czajkowski, National Correspondent Views

The U.S. House narrowly approved a budget framework with deep federal spending cuts that would likely target the Medicaid program.

After almost cancelling the vote in a last minute search for support, U.S. House Majority Leader Mike Johnson (R-La.) muscled [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GSK is Fourth Drugmaker to Reinstate Contract Pharmacy Restrictions in Kansas

February 25, 2025 Bella Czajkowski, National Correspondent Views

GlaxoSmithKline (GSK) has reinstated its 340B contract pharmacy restrictions in Kansas effective March 1.

UK-based drugmaker GlaxoSmithKline (GSK) will reinstate its contract pharmacy restrictions in Kansas next month, making it the fourth drug manufacturer [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Health Centers Host 340B Recertification Event In Lieu of HRSA’s Canceled Webinar

February 21, 2025 Bella Czajkowski, National Correspondent Views

Health center advocates hosted a webinar on the 340B recertification process this year after HRSA canceled its annual webinar.

After the Health Resources and Services Administration (HRSA) canceled its annual 340B grantee recertification webinar amid disruptions from a federal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Mississippi

February 21, 2025 Bella Czajkowski, National Correspondent Views

Key motions were recently filed in litigation over state contract pharmacy access laws in Mississippi.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live